BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32787519)

  • 1. Antiplatelet Effect of Carbon Monoxide Is Mediated by NAD
    Kaczara P; Sitek B; Przyborowski K; Kurpinska A; Kus K; Stojak M; Chlopicki S
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2376-2390. PubMed ID: 32787519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): comparison with NO donors.
    Chlopicki S; Lomnicka M; Fedorowicz A; Grochal E; Kramkowski K; Mogielnicki A; Buczko W; Motterlini R
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):641-50. PubMed ID: 22362133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Pharmacological Properties of Gaseous CO and CO-Releasing Molecule in Human Platelets.
    Kaczara P; Przyborowski K; Mohaissen T; Chlopicki S
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation into the mechanism(s) of antithrombotic effects of carbon monoxide releasing molecule-3 (CORM-3).
    Soni H; Jain M; Mehta AA
    Thromb Res; 2011 Jun; 127(6):551-9. PubMed ID: 21376373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function.
    Upadhyay KK; Jadeja RN; Vyas HS; Pandya B; Joshi A; Vohra A; Thounaojam MC; Martin PM; Bartoli M; Devkar RV
    Redox Biol; 2020 Jan; 28():101314. PubMed ID: 31514051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon monoxide released by CORM-A1 prevents yeast cell death via autophagy stimulation.
    Figueiredo-Pereira C; Menezes R; Ferreira S; Santos CN; Vieira HLA
    FEMS Yeast Res; 2019 Aug; 19(5):. PubMed ID: 31344236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme is required for carbon monoxide activation of mitochondrial BK
    Rotko D; Bednarczyk P; Koprowski P; Kunz WS; Szewczyk A; Kulawiak B
    Eur J Pharmacol; 2020 Aug; 881():173191. PubMed ID: 32422186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
    Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
    FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of exogenous carbon monoxide-releasing molecules 2 on endotoxin/lipopolysaccharide-induced abnormal activation of platelets of healthy human donors].
    Liu D; Zhuang M; Zhang J; Chen J; Sun B
    Zhonghua Shao Shang Za Zhi; 2015 Oct; 31(5):354-60. PubMed ID: 26714404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant potential of CORM-A1 and resveratrol during TNF-α/cycloheximide-induced oxidative stress and apoptosis in murine intestinal epithelial MODE-K cells.
    Babu D; Leclercq G; Goossens V; Remijsen Q; Vandenabeele P; Motterlini R; Lefebvre RA
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):161-78. PubMed ID: 26187750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon monoxide shifts energetic metabolism from glycolysis to oxidative phosphorylation in endothelial cells.
    Kaczara P; Motterlini R; Kus K; Zakrzewska A; Abramov AY; Chlopicki S
    FEBS Lett; 2016 Oct; 590(20):3469-3480. PubMed ID: 27670394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal inhibition of mouse mammary gland cancer metastasis by CORM-A1 and DETA/NO combination therapy.
    Porshneva K; Papiernik D; Psurski M; Łupicka-Słowik A; Matkowski R; Ekiert M; Nowak M; Jarosz J; Banach J; Milczarek M; Goszczyński TM; Sieńczyk M; Wietrzyk J
    Theranostics; 2019; 9(13):3918-3939. PubMed ID: 31281522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon monoxide released by CORM-401 uncouples mitochondrial respiration and inhibits glycolysis in endothelial cells: A role for mitoBKCa channels.
    Kaczara P; Motterlini R; Rosen GM; Augustynek B; Bednarczyk P; Szewczyk A; Foresti R; Chlopicki S
    Biochim Biophys Acta; 2015 Oct; 1847(10):1297-309. PubMed ID: 26185029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effect of CORM-2 on LPS-induced platelet activation by glycoprotein mediated HS1 phosphorylation interference.
    Liu D; Liang F; Wang X; Cao J; Qin W; Sun B
    PLoS One; 2013; 8(12):e83112. PubMed ID: 24376647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and platelet energy metabolism.
    Tomasiak M; Stelmach H; Rusak T; Wysocka J
    Acta Biochim Pol; 2004; 51(3):789-803. PubMed ID: 15448739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of neuronal differentiation by carbon monoxide: Role of pentose phosphate pathway.
    Almeida AS; Soares NL; Sequeira CO; Pereira SA; Sonnewald U; Vieira HLA
    Redox Biol; 2018 Jul; 17():338-347. PubMed ID: 29793167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle.
    Taillé C; El-Benna J; Lanone S; Boczkowski J; Motterlini R
    J Biol Chem; 2005 Jul; 280(27):25350-60. PubMed ID: 15863496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of multifunctional donors of carbon monoxide: Their anticoagulant, antioxidant, anti-aggregatory and cytotoxicity activities in an in vitro model.
    Adach W; Olas B
    Nitric Oxide; 2020 Apr; 97():20-26. PubMed ID: 32006712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.